- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
Weekly Investor Report
IGIS Value Plus REIT Co., Ltd. · Real Estate · Reit - Office
Mixed setup
The weekly trend is not active. Price is -7.5% below the Trend Line and sits at 29.4% of its 52-week range. The latest completed week returned 2.6%, after a 4.2% four-week move. The latest news-sentiment score is 56/100.
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -7.5% below the Trend Line and sits at 29.4% of its 52-week range. The latest completed week returned 2.6%, after a 4.2% four-week move.
52-week price path
Price vs Trend Line and Fair ValueIs real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price directionActivity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
12-week confirmation
No recent accumulation markers. No reversal markers.
Is performance persistent—and is the stock leading?
Performance is 4.2% over four weeks, -7.5% over 12 weeks, and -14.1% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Activity pressure vs relative leadership
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
No recent insider transactions are stored for this company.
Weighted news tone is neutral across 2 relevant articles.
1 positive · 1 neutral · 0 negativeActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signalWhat can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
Shape of recent returns
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
Four-week leaders
Four-week leaders
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Trend, activity pressure, participation, and risk combine to a 26/100 tape read.
Indicator analysis11/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.12; No reversal markers Next-Week ExpectancyNegative 44.95%Next-week expectancy is negative with a 44.95% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment56/100Weighted news tone is neutral across 2 relevant articles.
Niagen Bioscience (NAGE) On New Aging Study And The Case For A Higher Fair Value Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 3,580 KRW | 2.6% | 3,872 KRW | 3,991 KRW | -0.60 | -30.56 | 484.0K | Off |
| 31 Jul 2026 | 3,490 KRW | -1.6% | 3,893 KRW | 3,989 KRW | -0.89 | -36.83 | 838.4K | Off |
| 24 Jul 2026 | 3,545 KRW | 4.9% | 3,916 KRW | 3,988 KRW | -1.14 | -37.91 | 351.8K | Off |
| 17 Jul 2026 | 3,380 KRW | -1.6% | 3,937 KRW | 3,987 KRW | -1.37 | -43.02 | 400.0K | Off |
| 10 Jul 2026 | 3,435 KRW | -1.4% | 3,964 KRW | 3,987 KRW | -1.43 | -48.19 | 593.8K | Off |
| 3 Jul 2026 | 3,485 KRW | 1.8% | 3,992 KRW | 3,986 KRW | -1.53 | -52.40 | 70.4K | Off |
| 26 Jun 2026 | 3,425 KRW | -0.9% | 4,016 KRW | 3,985 KRW | -1.57 | -56.02 | 143.2K | Off |
| 19 Jun 2026 | 3,455 KRW | -1.4% | 4,044 KRW | 3,986 KRW | -1.52 | -59.70 | 118.4K | Off |
| 12 Jun 2026 | 3,505 KRW | 7.0% | 4,069 KRW | 3,985 KRW | -1.49 | -55.46 | 361.3K | Off |
| 5 Jun 2026 | 3,275 KRW | -8.7% | 4,089 KRW | 3,986 KRW | -1.44 | -59.52 | 417.4K | Off |
| 29 May 2026 | 3,589 KRW | -5.8% | 4,118 KRW | 3,987 KRW | -1.33 | -58.22 | 825.6K | Off |
| 22 May 2026 | 3,809 KRW | -1.6% | 4,141 KRW | 3,986 KRW | -1.17 | -53.18 | 719.7K | Off |
| 15 May 2026 | 3,871 KRW | -1.1% | 4,158 KRW | 3,984 KRW | -0.69 | -51.24 | 940.2K | Off |
| 8 May 2026 | 3,914 KRW | -2.2% | 4,164 KRW | 3,982 KRW | -0.60 | -51.74 | 916.1K | Off |
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.